LifeCareYou · LCY Intelligence A trend is not evidence. Every claim is assessed with its sources, limitations and conflicts of interest. Partner With Us
Launches · Ingredients · Market

Cosmetics Now

Follow new launches, notable ingredients and global market shifts in concise, sourced updates with clear advertising labels.

Last editorial review: 26 August 2026 Reviewed by: Cosmetics Product & Evidence Editor
Cosmetics Now INDEPENDENT EDITORIAL

A trend is not evidence. Every claim is assessed with its sources, limitations and conflicts of interest.

Affiliate revenue or sponsorship can never change an LCY evidence assessment.
01
INDEPENDENT EDITORIAL RESEARCH WATCH

Shade-matching science moves closer to retail

The Estée Lauder Companies and the University of Leeds announced a multi-year partnership in skin-tone and cosmetic colour science.

LCYLCY Verdict: The collaboration is verified; it does not yet prove retail performance or global accuracy.
Open the official release
02
INDEPENDENT EDITORIAL MARKET SIGNAL

U.S. retail expansion for K-Beauty

Sephora and Olive Young officially announced a partnership to bring a curated K-Beauty selection to U.S. consumers.

LCYLCY Verdict: A strong distribution signal; the announcement alone does not prove sales success.
Open the official release
03
INDEPENDENT EDITORIAL INGREDIENT CHECK

Ingredients come before serum names

Active, concentration, delivery system and tolerance are reviewed separately from marketing language.

LCYLCY Verdict: No definitive conclusion without the full formula.
Go to Evidence Meter
COSMETICS INTELLIGENCE

Five focus desks

A launch announcement, a market signal and a product claim are not the same thing. Every desk works with sources, dates and an LCY assessment.

01New Launch RadarClassifies new products by ingredient, price, market and claim type.02K-Beauty GlobalizationTracks Korean beauty retail, regional expansion and formulation shifts.03Fragrance EconomySeparates premiumisation, format changes and consumer demand.04Hair Treatment BoomReads the rise of serums, masks, oils and scalp care through evidence.05Ingredient IntelligenceAssesses actives with concentration, formulation and tolerance.
LCY / 2026

Sources and next steps

A launch story is not a clinical endorsement. The LCY Verdict separates ingredients, evidence, price context and market relevance.

Estée Lauder × University of Leeds official release

Follow new launches, notable ingredients and global market shifts in concise, sourced updates with clear advertising labels.

A launch story is not a clinical endorsement. The LCY Verdict separates ingredients, evidence, price context and market relevance.

A trend is not evidence. Every claim is assessed with its sources, limitations and conflicts of interest.

Estée Lauder × University of Leeds official release

Peer-reviewed cross-population colour study

Follow new launches, notable ingredients and global market shifts in concise, sourced updates with clear advertising labels.

A launch story is not a clinical endorsement. The LCY Verdict separates ingredients, evidence, price context and market relevance.

A trend is not evidence. Every claim is assessed with its sources, limitations and conflicts of interest.

Peer-reviewed cross-population colour study

Sephora × Olive Young official release

Follow new launches, notable ingredients and global market shifts in concise, sourced updates with clear advertising labels.

A launch story is not a clinical endorsement. The LCY Verdict separates ingredients, evidence, price context and market relevance.

A trend is not evidence. Every claim is assessed with its sources, limitations and conflicts of interest.

Sephora × Olive Young official release

Circana H1 2026 original market report

Follow new launches, notable ingredients and global market shifts in concise, sourced updates with clear advertising labels.

A launch story is not a clinical endorsement. The LCY Verdict separates ingredients, evidence, price context and market relevance.

A trend is not evidence. Every claim is assessed with its sources, limitations and conflicts of interest.

Circana H1 2026 original market report
Next section Evidence Meter